Netcall (LON:NET) Insider Nigel Halkes Acquires 5,000 Shares of Stock

Netcall plc (LON:NET) insider Nigel Halkes purchased 5,000 shares of the company’s stock in a transaction on Tuesday, March 17th. The shares were purchased at an average price of GBX 97 per share, with a total value of £4,850.

Netcall Stock Performance

LON NET opened at GBX 96.26 on Thursday. The firm has a market capitalization of £164.11 million, a P/E ratio of 39.94 and a beta of 0.23. Netcall plc has a 1-year low of GBX 88 and a 1-year high of GBX 138. The company has a debt-to-equity ratio of 2.06, a current ratio of 0.55 and a quick ratio of 0.88. The business’s 50-day simple moving average is GBX 116.39 and its 200-day simple moving average is GBX 116.36.

Netcall (LON:NET) last issued its earnings results on Wednesday, March 4th. The company reported GBX 2.43 earnings per share (EPS) for the quarter. Netcall had a return on equity of 5.23% and a net margin of 4.67%. Equities analysts predict that Netcall plc will post 3.7029017 EPS for the current year.

Analysts Set New Price Targets

Several research firms have recently issued reports on NET. Canaccord Genuity Group reissued a “buy” rating and issued a GBX 160 price objective on shares of Netcall in a research report on Wednesday, March 4th. Berenberg Bank restated a “buy” rating and set a GBX 165 target price on shares of Netcall in a report on Wednesday, March 4th. Two research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of GBX 162.50.

About Netcall

Netcall is a UK-based enterprise software company that unites automation and customer engagement in one AI-powered platform. Its Liberty platform makes work easier by digitising processes and simplifying customer interactions in a single, easy-to-use solution that reduces complexity. Today, around 600 organisations across healthcare, government and financial services rely on Netcall for mission‑critical workflows, including two‑thirds of NHS Acute Health Trusts and major enterprises such as Legal & General, Baloise and Santander.